|
|||||
|
|
The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer |
|
| Authors: | Ji Jie Xu Min-Xue Qian Tian-Yang Zhu Sheng-Ze Jiang Feng Liu Zhao-Xiu Xu Wei-Song Zhou Juan Xiao Ming-Bing |
| Institution: | 1.Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, People’s Republic of China ;2.Department of Gastroenterology and Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, No. 20 Xisi Road, Nantong, 226001, People’s Republic of China ;3.Medical College, Nantong University, Nantong, 226001, Jiangsu, People’s Republic of China ;4.Chinese Medicine 193, First Clinical Medical School, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China ;5.Department of Gastroenterology, Second People’s Hospital of Nantong, Nantong, 226001, Jiangsu, People’s Republic of China ;6.Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, People’s Republic of China ; |
| Abstract: | Molecular Biology Reports - Cervical cancer is the leading cause of cancer-related death among women worldwide. Identifying an effective treatment with fewer side effects is imperative, because all... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |